Product

Nula-Cel

Aliases

nula-cel Drug Product

1 clinical trial

1 indication

Indication

Sickle Cell Disease

Clinical trial

A Phase I/II Study of Nula-cel in Autologous CD34+ Hematopoietic Stem Cells to Convert HbS to HbA for Treating Severe Sickle Cell Disease

Status: Recruiting, Estimated PCD: 2026-07-31